Children's Hospital of Philadelphia Celebrates 500th Fetal Repair for Spina Bifida with Groundbreaking Achievements
The Children's Hospital of Philadelphia (CHOP) has reached a remarkable milestone by performing its 500th prenatal repair for spina bifida, specifically its most severe form, myelomeningocele (MMC). This accomplishment not only reflects the hospital's extensive expertise in fetal surgery but also illustrates decades of innovative research aimed at improving outcomes for affected families.
The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) has been at the forefront of pioneering techniques in fetal surgery since 1998. Originally viewed as a condition that could only be managed after birth, MMC is now treatable while the unborn child is still in the womb. The prevalence of spina bifida is about 1 in 2,000 births in the U.S., with MMC being the most common and severe form. In this condition, the spine does not completely close, exposing the spinal cord and nerves to potential damage from amniotic fluid.
The CHOP team has continuously refined its surgical methods, leading to significant advancements in the care of these patients. From 2003 to 2010, the hospital served as the lead site for the National Institutes of Health-funded Management of Myelomeningocele Study (MOMS), which was a groundbreaking trial demonstrating that in-utero repair significantly reduced the need for brain shunts and improved patient mobility compared to traditional postnatal repairs. The findings from this study reshaped fetal surgery protocols globally.
Moreover, the CFDT at CHOP stands out as the most experienced fetal surgery program worldwide, having performed over 2,700 fetal surgeries, including 500 specifically for MMC. During the open prenatal repair procedure, a specialized medical team carries out an incision in the mother's abdomen, utilizing ultrasound to navigate and carefully position the fetus for surgery. This intricate process involves sealing the exposed nerves and tissues, thereby protecting them from further injury and minimizing the risk of serious developmental complications such as hydrocephalus.
Achieving this milestone emphasizes CHOP’s commitment to clinical excellence and advancing research that informs and enhances patient outcomes. Dr. N. Scott Adzick, Co-Director of the CFDT, remarked, "Performing 500 fetal MMC repairs underscores CHOP's position as the world's leading fetal surgery center. This milestone reflects more than two decades of innovation, clinical excellence, and research dedicated to improving outcomes for children with spina bifida."
Since its inception in 1995, the CFDT has catered to over 36,214 expecting parents globally, collaborating with families from all 50 states and more than 70 countries. The program is designed to manage complex pregnancies where newborns require immediate medical attention or surgery post-delivery. Notably, the hospital's Garbose Family Special Delivery Unit (SDU) is the first of its kind in a pediatric facility, dedicated to welcoming babies with significant birth defects.
One inspiring story showcases Cassandra and Corey Rodriguez, who discovered during a routine ultrasound that their unborn child had spina bifida. After traveling to Philadelphia for evaluation and qualifying for the surgery, they experienced first-hand the seamless support and expertise of the CHOP team. Cassandra went on to successfully deliver Owen three months post-surgery, expressing, "From our first phone call, we felt extremely supported and cared for... This experience has changed how we parent – we hold our kids a little tighter and don’t take ordinary days for granted."
The Children's Hospital of Philadelphia, established in 1855, is a non-profit institution renowned for its commitment to transforming pediatric healthcare. With a strong focus on innovative research and exceptional patient care, it continues to set standards of excellence in the field of child health. Its dedication to family-centered care positions CHOP as a leading advocate for children both nationally and globally. To learn more about their groundbreaking work in fetal surgery and pediatric healthcare, visit CHOP's official website.
The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) has been at the forefront of pioneering techniques in fetal surgery since 1998. Originally viewed as a condition that could only be managed after birth, MMC is now treatable while the unborn child is still in the womb. The prevalence of spina bifida is about 1 in 2,000 births in the U.S., with MMC being the most common and severe form. In this condition, the spine does not completely close, exposing the spinal cord and nerves to potential damage from amniotic fluid.
The CHOP team has continuously refined its surgical methods, leading to significant advancements in the care of these patients. From 2003 to 2010, the hospital served as the lead site for the National Institutes of Health-funded Management of Myelomeningocele Study (MOMS), which was a groundbreaking trial demonstrating that in-utero repair significantly reduced the need for brain shunts and improved patient mobility compared to traditional postnatal repairs. The findings from this study reshaped fetal surgery protocols globally.
Moreover, the CFDT at CHOP stands out as the most experienced fetal surgery program worldwide, having performed over 2,700 fetal surgeries, including 500 specifically for MMC. During the open prenatal repair procedure, a specialized medical team carries out an incision in the mother's abdomen, utilizing ultrasound to navigate and carefully position the fetus for surgery. This intricate process involves sealing the exposed nerves and tissues, thereby protecting them from further injury and minimizing the risk of serious developmental complications such as hydrocephalus.
Achieving this milestone emphasizes CHOP’s commitment to clinical excellence and advancing research that informs and enhances patient outcomes. Dr. N. Scott Adzick, Co-Director of the CFDT, remarked, "Performing 500 fetal MMC repairs underscores CHOP's position as the world's leading fetal surgery center. This milestone reflects more than two decades of innovation, clinical excellence, and research dedicated to improving outcomes for children with spina bifida."
Since its inception in 1995, the CFDT has catered to over 36,214 expecting parents globally, collaborating with families from all 50 states and more than 70 countries. The program is designed to manage complex pregnancies where newborns require immediate medical attention or surgery post-delivery. Notably, the hospital's Garbose Family Special Delivery Unit (SDU) is the first of its kind in a pediatric facility, dedicated to welcoming babies with significant birth defects.
One inspiring story showcases Cassandra and Corey Rodriguez, who discovered during a routine ultrasound that their unborn child had spina bifida. After traveling to Philadelphia for evaluation and qualifying for the surgery, they experienced first-hand the seamless support and expertise of the CHOP team. Cassandra went on to successfully deliver Owen three months post-surgery, expressing, "From our first phone call, we felt extremely supported and cared for... This experience has changed how we parent – we hold our kids a little tighter and don’t take ordinary days for granted."
The Children's Hospital of Philadelphia, established in 1855, is a non-profit institution renowned for its commitment to transforming pediatric healthcare. With a strong focus on innovative research and exceptional patient care, it continues to set standards of excellence in the field of child health. Its dedication to family-centered care positions CHOP as a leading advocate for children both nationally and globally. To learn more about their groundbreaking work in fetal surgery and pediatric healthcare, visit CHOP's official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.